Vasoactive Intestinal Peptide

• Description:

  Vasoactive Intestinal Peptide_x000D_ Catalog number: B2014330_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 μg_x000D_ Molecular Weight or Concentration: 3325.80 g/mol_x000D_ Supplied as: Solution_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: Vasoactive Intestinal Peptide human, porcine, rat_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Prysor-Jones RA, Jenkins JS. Vasoactive intestinal peptide and anterior pituitary function Clin Endocrinol (Oxf). 1988 Dec;29(6):677-88._x000D_ 2: Davoren JB, Hsueh AJ. Vasoactive_intestinal peptide: a novel stimulator of steroidogenesis by cultured rat granulosa cells Biol Reprod. 1985 Aug;33(1):37-52._x000D_ 3: Sundler F, Ekblad E, Absood A, Hkanson R, Kves K, Arimura A. Pituitary adenylate cyclase activating peptide: a novel_vasoactive intestinal peptide-like neuropeptide in the gut Neuroscience. 1992;46(2):439-54._x000D_ 4: Wanke IE, Rorstad OP. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes Endocrinology. 1990 Apr;126(4):1981-8._x000D_ 5: Laburthe M, Prieto JC, Amiranoff B, Dupont C, Hui Bon Hoa D, Rosselin G. Interaction of vasoactive_intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive_ intestinal peptide on production of adenosine 3':5'-monophosphate Eur J Biochem. 1979 May 15;96(2):239-48._x000D_ 6: Dimaline R, Reeve JR Jr, Shively JE, Hawke D. Isolation and characterization of rat vasoactive_intestinal peptide Peptides. 1984 Mar-Apr;5(2):183-7._x000D_ 7: Gespach C, Bataille D, Vauclin N, Moroder L, W_nsch E, Rosselin G. Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology Peptides. 1986;7 Suppl 1:155-63._x000D_ 8: Beinfeld MC, Lewis ME, Eiden LE, Nilaver G, Pert CB. The distribution of cholecystokinin and vasoactive_intestinal peptide in rhesus monkey brain as determined by radioimmunoassay Neuropeptides. 1983 Jul;3(5):337-44._x000D_ 9: Dejda A, Matczak I, Wiktorowska-Owczarek A, Nowak JZ. Cyclic AMP formation in chicken brain: effect of vasoactive_intestinal peptide, peptide histidine-isoleucine (PHI), and some PHI-related peptides Pol J Pharmacol. 2003 Sep-Oct;55(5):747-51._x000D_ 10: Bernet F, Bernard J, Laborie C, Montel V, Maubert E, Dupouy JP. Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerular zone could be mediated by catecholamines via beta 1 adrenergic receptors Neurosci Lett. 1994 Jan 17;166(1):109-12. _x000D_ _x000D_ Products Related to Vasoactive Intestinal Peptide can be found at Peptides

• Short Description:

  Catalog Number: B2014330 (50 μg)_x000D_ Vasoactive Intestinal Peptide is a high quality Vasoactive Intestinal Peptide human, porcine, rat. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5